Article Information
History
- July 2, 2020.
Article Versions
- You are currently viewing Version 1 of this article (July 2, 2020 - 02:07).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- M Famulare1,†,
- W Wong1,†,
- R Haque2,
- JA Platts-Mills3,
- P Saha2,
- AB Aziz2,
- T Ahmed2,
- MO Islam2,
- MJ Uddin3,
- AS Bandyopadhyay4,
- M Yunus2,
- K Zaman2,‡ and
- M Taniuchi3,‡,*
- 1Institute for Disease Modeling, Global Good, Intellectual Ventures, Bellevue, WA, USA
- 2International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
- 3Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, USA
- 4Bill & Melinda Gates Foundation, Seattle, WA, USA
- ↵*Corresponding Author
Mami Taniuchi., Division of Infectious Diseases and International Health, University of Virginia, PO 801340, Charlottesville, VA 22901, +1 (434) 924-5575, Email: mt2f{at}virginia.edu
↵†, ‡ These authors contributed equally
Author Contributions MT, MF, KZ, RH, JPM, WP, AB, contributed to the original clinical trial study design, data acquisition, analysis, interpretation, and writing. PS and ABA contributed to field activities and TA, MOI, and MJU contributed to lab data acquisition and analysis. MF and WW led the mathematical modeling design and analyses. Correspondence and requests for materials should be addressed to Mami Taniuchi.
Posted July 02, 2020.
